3652 results for «238»

Filter By

3652 results

Treatment of in-stent restenosis

16 May 2023 – From EuroPCR 2023

Looking for a recap of this case-based session to refresh your memory? Don't miss these slides and review the diagnostic and management details of each case.

In-stent restenosis case

Endovascular management treatment

17 May 2023 – From EuroPCR 2023

In this series of resources, explore the toolbox for BTK bifurcation treatment with antegrade and retrograde management, navigate complex scenarios in superficial femoral artery and femoral bifurcation and  elevate your expertise in carotid artery stenting managment. 

Endovascular management treatment

Mitral and tricuspid valve intervention : new devices and clinical outcomes

17 May 2023 – From EuroPCR 2023

Need a reminder on this session about the new devices and clinical outcomes in mitral and tricuspid valve intervention? Take a look at these slides and review the essential in a glance.

Mitral and tricuspid valve intervention

Bifurcations

17 May 2023 – From EuroPCR 2023

Seeking to revive your understanding of this session focusing on bifurcations? Examine these slides and review the main elements of the presentations.

Bifurcations in interventional cardiology

Working in the cathlab makes everyday different

17 May 2023 – From EuroPCR 2023

Experience the dynamic cathlab environment, where each day brings unique challenges. These slides will cover diverse topics such as pulmonary ductus arteriosus, coronary artery fistula, TAVI with mechanical mitral valve, and much more!

Working in the cathlab makes everyday different

Novel treatment strategies in ACS patients

17 May 2023 – From EuroPCR 2023

Seeking to revive your understanding on novel strategies in ACS treatment? Explore this collection of resources to get insight on optimal antithrombotic therapy in AF patients post-PCI, complete revascularisation in ACS, and early invasive approaches in high-risk NSTEMI, among other topics. 

Novel treatment strategies in ACS patients

Coronary artery disease: more imaging, less imagination

18 May 2023 – From EuroPCR 2023

In these slides, explore associations between angiography-based FFR and OCT-detected luminal obstruction, prognostic impact of ischaemia vs. plaque vulnerability, CT's mortality foresight, and much more.

Coronary artery disease: more imaging, less imagination

TAVI 1: durability, mismatch and challenging anatomy

18 May 2023 – From EuroPCR 2023

Explore TAVI longevity: Five-year Portico valve outcomes, bioprosthetic dysfunction post-surgery or self-expanding TAVI, prosthesis-patient mismatch impact, and innovative valve-in-valve TAVI insights, and more.

TAVI 1: durability, mismatch and challenging anatomy

Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

29 Mar 2025

Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

Author

Aaysha Cader
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction

03 Apr 2022

Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.

Nicola Ryan

Author

Nicola Ryan
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected CAD: the PRECISE randomized trial

09 Nov 2022

Alex Sticchi provides his take on PRECISE, which was presented during AHA 2022 in Chicago.

Alessandro Sticchi

Author

Alessandro Sticchi
Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected coronary artery disease: the PRECISE randomized trial
Didn’t find what you were looking for?